A Study of the Efficacy of Atorvastatin Alone and Its Combination with Omega-3 Fatty Acids in Patients with Hyperlipidemia
Journal Title: Saudi Journal of Medical and Pharmaceutical Sciences - Year 2018, Vol 4, Issue 8
Abstract
Atherosclerosis is one of the major causes of increased morbidity and mortality associated with coronary artery disease, cerebrovascular accidents, and peripheral vascular diseases. Dyslipidemia is one of the important causes that result in atherosclerosis. The incidence of atherosclerosis has been on the rising recently. Therefore prevention of dyslipidemia can decrease the development of atherosclerosis. Aims: The study was undertaken to determine the efficacy of atorvastatin alone and its combination with omega-3 fatty acids in the management of hyperlipidemia in patients attending a tertiary care hospital. Methods: This study was a cross-sectional prospective study conducted in the Department of Pharmacology and General Medicine, Kakatiya Medical College and Hospital, Warangal. The patients were selected from those visiting General Medicine OPD and diagnosed with hyperlipidemia. Sixty patients in the age group of 20 – 70 yrs, were recruited based on inclusion and exclusion criteria. They were divided into two groups. The Group I included the patients receiving Tab. Atorvastatin 10mg/day and Group II Atorvastatin 10mg/day plus Cap Omega-3 fatty acids 600mg/day for the duration of six months and follow up were done every month. Efficacy of treatment was assessed by the changes in laboratory parameters of Total cholesterol, Triglycerides, HDL-C, LDL-C, and VLDL-C. Results: The efficacy of combination therapy i.e., Atorvastatin plus Omega-3 fatty acids showed a statistically significant rise in HDL cholesterol with the mean percentage difference of 4.24% when compared to monotherapy with Atorvastatin. The efficacy of other parameters like total cholesterol (TC), LDL cholesterol, VLDL cholesterol, and triglycerides (TG'S) levels with the low dose of omega-3 fatty acids in combination therapy was not statistically significant and produced nearly identical alterations in serum lipoprotein levels when compared to monotherapy. Conclusion: Although statins are being used as first-line therapy for hyperlipidemia and in patients with elevated triglycerides. For patients with elevated LDL-C and low HDL-C combination therapy appears to be a better option. Thus omega-3 fatty acids may be a potential supplement for combination therapy apart from niacin and fibrates.
Authors and Affiliations
Dr. Madhukar Rao Polasani, Dr. Swathi C
Keywords
Related Articles
- EP ID EP481627
- DOI -
- Views 71
- Downloads 0
Development and Validation of Stability Indicating Method for the Simultaneous Estimation of Batcaver Sulfate, Lamivudine and Dolutegravir Sodium in Pharmaceutical Dosage forms by RP-HPLC
Abstract:A simple, rapid, specific, stability indicating method was developed and validated for the simultaneous estimation of Abacavir sulfate, Lamivudine and Dolutegravir sodium in pharmaceutical dosage form using RP-H...
Tai Chi as a Physiotherapeutic Approach against Osteoarthritis and Oxidative Stress
Abstract:Osteoarthritis (OA) is the most prevalent degenerative joint disease and the most important reason of the physical disability in the elderly population. Along with the fact that OA pathogenesis is not fully know...
A Novel Spectrofluorimetric Method for the Estimation of Gefitinib in Raw Material and Pharmaceutical Dosage Form
Abstract:A simple and sensitive spectrofluorimetric method has been developed for the estimation of Gefitinib in pure and pharmaceutical dosage form. Gefitinib exhibits maximum fluorescence intensity in ethanol and Beer’...
Vernal Keratoconjunctivitis with Giant Papillae as Manifestation of Post Streptococcal Syndrome: Report of the First Case and Review of the Literature
Vernal keratoconjunctivitis (VKC) is an unusually severe allergic eye disease, occurring mainly in children. Giant papillae are frequently observed on the upper tarsal conjunctiva and expose, sometimes, to severe corneal...
Deafness Management in Children with the Charge Association
Abstract:The acronym CHARGE is used to describe specific congenital birth defects in children: Colobomata, Heart defect, Atresia of the choanae, Retarded growth or development, Genital hypoplasia, and Ear anomalies or de...